NeoTherma Oncology

About:

NeoTherma Oncology is a Bioelectric device developer.

Website: http://www.neothermaoncology.com/

Top Investors: R & K Edwards Investments, Gary Barnett, Flor-Med Partners

Description:

NeoTherma Oncology is developing VectRx™, a noninvasive thermal oncology therapeutic device system for treatment of a wide range of cancers in addition to Pancreatic Ductal Adenocarcinoma, the eighth most common cancer but the fourth leading cause of cancer death in the United States. VectRx is designed to ‘plug and play’ with the global installed base of MRI scanners to deliver non-invasive, image-guided adjuvant thermal oncology therapy, which is expected to increase life expectancy and improve quality of life of patients who receive it in addition to standard-of-care radio-, chemo- and immuno- therapies.

Total Funding Amount:

$6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wichita, Kansas, United States

Founded Date:

2015-01-01

Founders:

John Kanzius

Number of Employees:

1-10

Last Funding Date:

2018-08-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai